In our case, to investigate further for evidence, the anti-NMDAR antibodies were tested and the anti-GluR1 antibody highly specific for anti-NMDAR encephalitis was found to be positive, suggesting the diagnosis of anti-NMDAR encephalitis with overlapping MS. The gene discussed is GRIA1; the disease is myeloid sarcoma.